Mohammad Rezaul Islam Shishir | Cell Structure Analysis | Best Researcher Award

Posted on by sciencefather

Dr. Mohammad Rezaul Islam Shishir | Cell Structure Analysis | Best Researcher Award

Dr. Mohammad Rezaul Islam Shishir , Jiangsu University , China

Dr. Mohammad Rezaul Islam Shishir is an accomplished researcher in the field of food science and engineering, specializing in food bioactive compounds, micro and nano-encapsulation, and functional food formulation. With a strong academic background and extensive research experience, he has contributed significantly to developing advanced delivery systems for bioactive compounds. His research focuses on enhancing the stability, bioavailability, and controlled-release properties of natural products. Currently serving as a Postdoctoral Researcher at Jiangsu University, China, Dr. Shishir has received prestigious awards, including the Jiangsu Provincial Excellent Postdoctoral Award. His groundbreaking research in nanoliposomal delivery and food-based smart carriers has led to numerous high-impact publications in renowned journals. His dedication to innovation and scientific advancement makes him a prominent figure in food science, contributing to both academia and the food industry.

Publication Profile:

Scopus

Strengths for the Award:

βœ… Extensive Research Experience – Dr. Shishir has a strong background in food science, particularly in nano-encapsulation and functional food development.
βœ… High-Impact Publications – His research has been published in top-tier journals such as Food Chemistry, Food Hydrocolloids, and Comprehensive Reviews in Food Science and Food Safety, with impact factors reaching up to 15.1.
βœ… Innovative Research – His work on nanoliposome-based drug delivery and cold plasma-assisted food processing has significantly contributed to food science advancements.
βœ… Recognized Excellence – Awarded the Jiangsu Provincial Excellent Postdoctoral Award (2023ZB876), highlighting his contributions to scientific innovation.

Areas for Improvement:

πŸ”Ή Interdisciplinary Collaboration – Expanding research collaborations across medical and pharmaceutical fields could further enhance the practical applications of his work.
πŸ”Ή Patent & Commercialization – Translating research findings into patents and commercial food products would increase real-world impact.
πŸ”Ή Leadership in Grant Projects – Leading large-scale international grants and mentorship programs could elevate his recognition in the global research community.

Education πŸŽ“

Dr. Mohammad Rezaul Islam Shishir has an extensive educational background in food engineering and food science. He completed his PhD in Food Science (2016–2020) from Zhejiang University, China, where he focused on improving the stability and functionality of nanoliposome-based delivery systems. His MSc in Food Engineering (2013–2016) was earned from Universiti Putra Malaysia, Malaysia, where he specialized in advanced food processing techniques. Dr. Shishir began his academic journey with a BSc in Food and Process Engineering (2007–2011) from Hajee Mohammad Danesh Science & Technology University, Bangladesh. His studies have equipped him with expertise in food bioactive compounds, nano-encapsulation, and smart delivery systems for functional foods. His academic training, combined with hands-on research, has positioned him at the forefront of food innovation, working towards the development of efficient and sustainable food processing technologies.

Experience πŸ‘¨β€πŸ”¬

Dr. Mohammad Rezaul Islam Shishir is currently a Postdoctoral Researcher (June 2023 – Present) at the School of Food and Biological Engineering, Jiangsu University, China. His research focuses on developing nanoliposome-embedded double-network composite hydrogel beads for gastrointestinal delivery of quercetin. During his PhD at Zhejiang University, he contributed to two major projects: nanoliposomal delivery systems and cold plasma-assisted drying of shiitake mushrooms. His expertise extends to food bioactive compounds, micro and nano-encapsulation, and functional food formulations. Throughout his career, Dr. Shishir has developed novel nanofiber solosomes, complex coacervates, emulsions, and lipo-beads for improved bioavailability and stability of bioactive compounds. His work has led to significant advancements in the controlled-release delivery of natural compounds in food products, making his research highly valuable for both academia and industry.

Awards & HonorsπŸ†

Dr. Mohammad Rezaul Islam Shishir has been recognized for his outstanding contributions to food science research. He was awarded the prestigious Jiangsu Provincial Excellent Postdoctoral Award (2023ZB876) in 2023, offered by the Jiangsu Provincial Party Committee, Department of Human Resources and Social Security, and Department of Finance, China. This award, valued at 300,000 CNY (~$41,600), is a testament to his remarkable research achievements in functional food formulation and nanotechnology-based delivery systems. His innovative approaches to enhancing bioactive compound stability and bioavailability have been widely acknowledged in the scientific community. His dedication to advancing food science, coupled with his contributions to high-impact research, make him a strong candidate for prestigious research awards.

Research Focus πŸ”¬

Dr. Mohammad Rezaul Islam Shishir’s research focuses on food bioactive compounds, micro and nano-encapsulation, and functional food development. He specializes in fabricating nanoliposomes, nanofibers, microbeads, emulsions, and lipo-beads to improve the stability, bioavailability, and controlled-release of natural compounds. His work also includes the synthesis of functional biopolymers for surface coating and cross-linking to develop smart delivery systems for bioactive ingredients. His projects have explored the use of lactoferrin, chia seed mucilage, and pectin-chitosan nanoliposomes for improved nutrient absorption and targeted delivery in the human body. By integrating cutting-edge techniques such as stimuli-responsive carriers and cold plasma technology, Dr. Shishir’s research aims to revolutionize the food and nutraceutical industries by ensuring better stability, enhanced functionality, and improved consumer health benefits.

Publications Top Notes πŸ“š

1️⃣ Lactoferrin-chia seed mucilage complex coacervates for intestinal delivery of quercetin and fortification of set yogurt – Food Chemistry (2024)
2️⃣ Micro and nano-encapsulated natural products in yogurt: An emerging trend to achieve multifunctional benefits in product quality and human health – Food Hydrocolloids (2024)
3️⃣ Seed mucilage carrier systems for food and nutraceuticals: fabrication, formulation efficiency, recent advancements, challenges, and perspectives – Critical Reviews in Food Science and Nutrition (2023)
4️⃣ Advances in smart delivery of food bioactive compounds using stimuli-responsive carriers – Comprehensive Reviews in Food Science and Food Safety (2021)
5️⃣ Development and evaluation of a novel nanofibersolosome for enhancing the stability, in vitro bioaccessibility, and colonic delivery of cyanidin-3-O-glucoside – Food Research International (2021)
6️⃣ Improving the physicochemical stability and functionality of nanoliposome using green polymer for the delivery of pelargonidin-3-O-glucoside – Food Chemistry (2021)
7️⃣ Colonic delivery of pelargonidin-3-O-glucoside using pectin-chitosan-nanoliposome: Transport mechanism and bioactivity retention – International Journal of Biological Macromolecules (2020)
8️⃣ Pectin-chitosan conjugated nanoliposome as a promising delivery system for neohesperidin – Food Hydrocolloids (2019)
9️⃣ Liposomal delivery of natural products: A promising approach in health research – Trends in Food Science & Technology (2019)
πŸ”Ÿ Cold plasma pretreatment – A novel approach to improve the hot air-drying characteristics and nutritional attributes of shiitake mushroom – Drying Technology (2019)

Conclusion

Dr. Mohammad Rezaul Islam Shishir’s expertise in food bioactive compounds, nano-encapsulation, and functional foods positions him as a highly deserving candidate for the Best Researcher Award. His publications in high-impact journals, combined with his innovative research on food delivery systems and bioactive compound stability, make him an outstanding researcher in his field. Strengthening industry collaborations and expanding his influence in applied food science would further solidify his legacy.

Hatice Yesim Karasulu | Cell Differentiation Processes | Best Innovation Award

Posted on by sciencefather

Prof. Dr. Hatice Yesim Karasulu | Cell Differentiation Processes | Best Innovation Award

Prof. Dr. Hatice Yesim Karasulu , Ege University, Faculty of Pharmacy, Pharmaceutical Technology , Turkey

Prof. Dr. H. Yeşim Karasulu is a distinguished academic and researcher in pharmaceutical technology, based at Ege University in Turkey. With a career spanning decades, she earned her Ph.D. in Pharmaceutical Technology from Ege University, where she became an Associate Professor in 2006 and a full Professor in 2011. Prof. Karasulu has held numerous positions, including consultant for the Ege University Center for Drug Research & Development (ARGEFAR) and member of the pharmaceutical technology commission at Turkey’s Ministry of Health from 2006 to 2024. She has contributed extensively to drug delivery systems and pharmaceutical formulations, especially focusing on colloidal drug delivery. Over the years, she has published over 50 research papers, authored five book chapters, and is the holder of two patents related to nano-drug delivery systems. Her work has advanced both academic knowledge and pharmaceutical industry practices.

Publication Profile:

Google Scholar

Strengths for the Award:

  1. Extensive Research Experience: Prof. Dr. H. Yeşim Karasulu has an exceptional track record with more than 50 publications, multiple patents, and ongoing research projects. Her innovative work in colloidal drug delivery systems, including liposomes, nano/microparticles, nano/microemulsions, and self-emulsifying drug delivery systems (SEDDS), positions her as a leading researcher in the pharmaceutical field.
  2. High Impact and Collaboration: Her research is widely cited with an H-index of 16 (WoS) and 18 (Scopus). She has collaborated with prestigious institutions such as the University of Vienna and the Aristotle University of Thessaloniki, further enhancing the global impact of her work.
  3. Patent and Industry Collaboration: Prof. Karasulu’s research has led to two patents and several patent applications, showcasing the practical and commercial value of her innovations. Additionally, her collaborative efforts with the pharmaceutical industry in developing drug delivery systems highlight her ability to bridge academia and industry, enhancing the potential for real-world applications.
  4. Ongoing Research Projects: Prof. Karasulu is involved in multiple research projects, both academic and industry-sponsored, demonstrating her continuous commitment to advancing pharmaceutical sciences. Her ongoing projects include drug delivery systems targeting specific organs and improving drug bioavailability and stability.
  5. Awards and Recognition: Prof. Karasulu’s achievements are recognized through awards such as the Ege ArGe First Prize and the Ege ArGe Innovation Award, confirming the innovative nature of her research.

Areas for Improvement:

  1. Broader International Visibility: While Prof. Karasulu has a strong track record within her field, expanding her international visibility by increasing collaborations with leading global pharmaceutical companies could further enhance the global reach and impact of her innovations.
  2. Diversity of Published Works: Though Prof. Karasulu has an impressive number of publications, exploring opportunities for publication in high-impact journals outside her primary research focus could enhance her visibility in other areas of pharmaceutical sciences.
  3. Focus on Translational Research: While there is a strong emphasis on preclinical studies and formulation development, further focus on clinical trials and commercialization of her innovations could enhance the practical application of her work, especially with regard to regulatory approval processes for new drug delivery systems.

Education:

Prof. Dr. H. Yeşim Karasulu pursued her academic studies at Ege University in Izmir, Turkey. She completed her Bachelor’s degree in Pharmacy at the Faculty of Pharmacy before obtaining a Ph.D. in Pharmaceutical Technology from the same institution. Her education continued with postdoctoral research at the University of Vienna, focusing on Pharmaceutical Technology and Biopharmaceutics under the guidance of Prof. Dr. Franz Gabor. This international research experience allowed her to expand her expertise in colloidal drug delivery systems, setting the foundation for her career as a researcher. Throughout her education, Prof. Karasulu’s work has concentrated on the development of drug delivery systems, with an emphasis on enhancing the bioavailability and targeting of drugs using innovative methods like liposomes, nano/microparticles, and microemulsions. Her academic background has enabled her to contribute significantly to both research and industry practices in pharmaceutical sciences.

Experience:

Prof. Dr. H. Yeşim Karasulu has a distinguished career in both academia and the pharmaceutical industry. She began her academic career as a faculty member at Ege University, where she progressed from an Assistant Professor to a full Professor in the Department of Pharmaceutical Technology. Additionally, she has been an active consultant at the Ege University Center for Drug Research & Development (ARGEFAR) since 2011. Prof. Karasulu also served as a member of the Pharmaceutical Technology Commission at the Turkish Ministry of Health’s Pharmaceuticals and Medical Devices Agency between 2006 and 2024, helping shape national pharmaceutical policies. Her extensive research has led to breakthroughs in nano-drug delivery systems, contributing to the development of two patents and several industry projects. She has worked on numerous national and international projects focusing on drug formulation, bioavailability enhancement, and targeting systems, particularly for cancer therapy and chronic diseases.

Research Focus:

Prof. Dr. H. Yeşim Karasulu’s research primarily focuses on the development and evaluation of advanced colloidal drug delivery systems. Her work spans liposomes, nano/microparticles, nano/microemulsions, and self-emulsifying drug delivery systems (SEDDS). These innovative systems aim to enhance the bioavailability, stability, and targeted delivery of pharmaceutical compounds. Prof. Karasulu has led several high-impact research projects funded by both national (TUBΔ°TAK) and international bodies, such as the European Union. Her research is dedicated to improving the therapeutic efficacy of drugs, particularly in challenging areas like cancer treatment and chronic diseases. Prof. Karasulu’s work is closely aligned with real-world applications, as evidenced by her ongoing collaboration with the pharmaceutical industry to bring new drug delivery systems to market. Her goal is to create formulations that not only improve patient outcomes but also contribute to the overall advancement of pharmaceutical technology.

Publications Top Notes:

  1. “Degradation and gastrointestinal stability of nitrofurantoin in acidic and alkaline media” πŸ“‰πŸ’Š
  2. “Sustained-release dosage form of nitrofurantoin: Part 1. Preparation of microcapsules and in vitro release kinetics” πŸ’ŠπŸ”¬
  3. “33 factorial design-based optimization of the formulation of nitrofurantoin microcapsules” πŸ”¬πŸ“Š
  4. “In vitro-in vivo correlations of nitrofurantoin matrix tablet formulation” πŸ’Šβš–οΈ
  5. “A New In Vitro/In Vivo Kinetic Correlation Method for Nitrofurantoin Matrix Tablet Formulations” πŸ§ͺπŸ’‘
  6. “Sustained release bioadhesive effervescent ketoconazole microcapsules tabletted for vaginal delivery” πŸ’ŠπŸ’₯
  7. “Different geometric shaped hydrogel theophylline tablets: Statistical approach for estimating drug release” πŸ’ŠπŸ“
  8. “Extended release lipophilic indomethacin microspheres: formulation factors and mathematical equations fitted drug release rates” πŸ’ŠπŸ”’
  9. “Improving of the accuracy of in vitro-in vivo linear correlation using kinetic models for ultra sustained release theophylline tablets” πŸ§ͺπŸ“Š
  10. “Efficacy of a new ketoconazole bioadhesive vaginal tablet on Candida Albicans” πŸ’ŠπŸ¦ 
  11. “Preparation of arsenic trioxide-loaded microemulsion and its enhanced cytotoxicity on MCF-7 breast carcinoma cell line” πŸ”¬πŸ§ͺ
  12. “In vitro permeation of diclofenac sodium from novel microemulsion formulations through rabbit skin” πŸ’ŠπŸ‡
  13. “Arsenic trioxide-loaded, microemulsion-enhanced cytotoxicity on MDAH 2774 ovarian carcinoma cell line” πŸ”¬πŸ’‰
  14. “Transdermal delivery of diclofenac sodium through rat skin from various formulations” πŸ’ŠπŸ¦·
  15. “Controlled release of methotrexate from W/O microemulsion and its in vitro anti-tumor activity” πŸ§ͺπŸ’₯

Conclusion:

Prof. Dr. H. Yeşim Karasulu is a highly deserving candidate for the Best Innovation Award. Her groundbreaking research in colloidal drug delivery systems has significantly contributed to advancements in pharmaceutical sciences. With numerous publications, patents, and collaborations, her work not only pushes the boundaries of scientific research but also has a profound impact on drug development. By focusing on broader international collaborations and further developing translational research strategies, Prof. Karasulu’s contributions to the pharmaceutical industry and academic community will continue to grow, solidifying her place as a leader in innovation.